Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

By D. Nathan, John B. Buse, M. Davidson, R. Heine, Rury R. Holman, R. Sherwin, B. Zinman. Diabetes Care, 2006

954 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/ff61a66f877fba815b2e7a1218aeeb2276b788bf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. V. Basevi
2. D. Nathan
3. Ralph DeFronzo
4. E. Ferrannini
5. John B. Buse
6. B. Zinman
7. G. Bakris
8. Å. Lernmark

In Molecular Biology

1. Ralph DeFronzo
2. D. Nathan
3. Rury R. Holman
4. John B. Buse
5. V. Basevi
6. K. Bornfeldt
7. I. Tabas

Citations in the corpus

• Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008, neutral): “Although the data are less than conclusive for a CVD risk with rosiglitazone or a CVD benefit with pioglitazone, we have previously advised [69] caution in using either TZD, on the basis that they are both associated with increased risks of fluid retention and congestive heart failure, and an increa”
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009, methodology): “Although the data are less than conclusive for a CVD risk with rosiglitazone or a CVD benefit with pioglitazone, we have previously advised (69) caution in using either TZD on the basis that they are both associated with increased risks of fluid retention and congestive heart failure and an increase”
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2009, methodology): “The correlation between A1C levels and complications has also been shown in the setting of controlled clinical trials in type 1 (28) and type 2 (29) diabetes, and these findings have been used to establish the widely accepted A1C treatment goals for diabetes care (30).”
• Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “The ADA and other organizations that have addressed this issue recommend HbA1c measurement in both type 1 and type 2 diabetic patients to document the degree of glycemic control and to assess response to therapy (21,93,201).”